CD4/CD8 Ratio could be predictor of burden hepatocellular carcinoma in Egyptian chronic hepatitis C after combined sofosbuvir and daclatasvir therapy

BACKGROUND: During the first years of the use of direct acting Hepatitis C antiviral drugs (DAAS), several studies reported a possible correlation between this new era of treatment and an increased risk of Hepatocellular carcinoma (HCC). Its development could possibly be favored by the changes in th...

Descripción completa

Detalles Bibliográficos
Autores principales: El Menshawy, Nadia, Hassan, Noha, Khariza, Mohamed, AlAshery, Hala, Baghat, Monir, Ashour, Rehab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398471/
https://www.ncbi.nlm.nih.gov/pubmed/37545943
http://dx.doi.org/10.4314/ahs.v23i1.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398471/
https://www.ncbi.nlm.nih.gov/pubmed/37545943
http://dx.doi.org/10.4314/ahs.v23i1.22

Ejemplares similares